Related Experiment Videos

Postantibiotic effects and Burkholderia (Pseudomonas) pseudomallei: evaluation of current treatment

A L Walsh1, M D Smith, V Wuthiekanun

  • 1Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

Insights

The study determined postantibiotic effects (PAEs) for 16 antibiotics against Burkholderia pseudomallei. Carbapenems and ciprofloxacin showed significant PAEs, unlike beta-lactams, informing severe melioidosis treatment.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Melioidosis, caused by Burkholderia pseudomallei, is a severe infectious disease.
  • Understanding the postantibiotic effect (PAE) is crucial for optimizing antibiotic dosing strategies.
  • Current treatment guidelines for melioidosis require evaluation based on antimicrobial efficacy.

Purpose of the Study:

  • To determine the postantibiotic effects (PAEs) of 16 commonly used antibiotics or antibiotic combinations against Burkholderia pseudomallei.
  • To compare the PAEs induced by different antibiotic classes, including beta-lactams, carbapenems, and fluoroquinolones.
  • To provide data that can inform optimal antibiotic dosing regimens for severe melioidosis.

Main Methods:

  • Bacterial cultures of Burkholderia pseudomallei were exposed to 16 different antibiotics or combinations.
  • Postantibiotic effects were measured by determining the duration of bacterial growth inhibition after antibiotic removal.
  • Median PAEs were calculated for each antibiotic tested.

Main Results:

  • Beta-lactam antibiotics exhibited negligible or zero postantibiotic effects against Burkholderia pseudomallei.
  • Carbapenems demonstrated a median PAE of 1 hour.
  • Ciprofloxacin induced a median PAE of 5 hours, indicating a more prolonged suppressive effect.

Conclusions:

  • Antibiotic selection for severe melioidosis should consider the duration of postantibiotic effect.
  • Maintaining antibiotic concentrations above the minimum inhibitory concentration (MIC) throughout the dosing interval is critical.
  • Ciprofloxacin and carbapenems may offer advantages over beta-lactams in managing severe melioidosis due to their PAEs.

Related Concept Videos